14C dating of the last Croscat volcano eruption (Garrotxa Region, NE Iberian Peninsula)

In this shortnote, we present the results of a geochronological study of the last eruption in the volcanic region of the Garrotxa (NE Iberian Peninsula). Four 14C analysis of organic matter contained in palaeosols located under volcanic pyroclastic fall deposits of the Croscat volcano were made. The samples gave ages between 13160 and 15710 years cal BP, and are in accord with our palynological analysis and climate reconstruction at that time. The ages that we report are the youngest obtained for volcanic activity in the Iberian Peninsula

Medida de calidad asistencial que se ofrece a los pacientes con intoxicaciones agudas en el Servicio de Urgencias

Objetivo: Medir la calidad asistencial ofrecida en el Servicio de Urgencias (SU) a los pacientes intoxicados, mediante un mapa de indicadores. Método: Se diseñan 25 indicadores de calidad (6 estructurales, 15 funcionales y 4 administrativos), definiendo unos estándares mínimos. Se evalúa la asistencia que reciben los intoxicados atendidos durante un mes, utilizando los mencionados indicadores, y analizando los informes asistenciales, médico y de enfermería, y los documentos administrativos del paciente. Resultados: Se han valorado 139 intoxicados. Se disponía del protocolo terapéutico, de los antídotos necesarios y de sondas gástricas adecuadas en el 100% de los casos. La analítica toxicológica cualitativa estaba disponible en el 89% y la cuantitativa en el 49%. El tiempo transcurrido entre la llegada al SU y la atención al paciente fue inferior a 15 min en el 78% de casos. El intervalo entre la llegada al SU y el inicio de la descontaminación digestiva fue inferior a 15 min en el 57% de casos. La aplicación adecuada de los diversos algoritmos de valoración clínica, diagnóstico y tratamiento osciló entre un 50 y un 95%. Los registros de presión arterial, frecuencia cardiaca, respiratoria y temperatura constaban entre un 35 y un 81% de los pacientes. El parte judicial se realizó en el 31% de los casos y la interconsulta con el psiquiatra en todos los intentos de suicidio. La mortalidad fue del 0%. Conclusiones: El SU ofrece a los intoxicados una calidad asistencial satisfactoria en aspectos estructurales (protocolos y técnicas analíticas), debe mejorarse a nivel funcional (aplicación de técnicas y tiempos de atención) y muestra deficiencias en los aspectos administrativo

Emergencies related to recreational drug abuse in Spain compared to emergencies attended in 3 European areas.

[Please note: the full article is in Spanish.] OBJECTIVES: To analyze epidemiologic, clinical, and care characteristics in cases in which patients came to 2 Spanish emergency departments (EDs) with symptoms caused by recreational drug abuse. To compare the characteristics with those reported for other areas of Europe. MATERIAL AND METHODS: Secondary analysis of the registry of the European Drug Emergencies Network (Euro-DEN Plus), which collects cases in 14 European countries and 20 EDs. The registry included all patients attending EDs with symptoms of recreational drug abuse (excepting cases involving alcohol alone) over a period of 39 consecutive months (October 2013 to December 2016). We compared the cases from the 2 Spanish EDs (in Barcelona and Palma de Mallorca) to those from the 5 EDs in Ireland and the UK, 6 in northern Europe, and 7 in central Europe. RESULTS: A total of 17 104 patients' cases were included: Spain, 1186; UK and Ireland, 6653; northern Europe, 6097; and central Europe, 3168. Spain saw more emergencies related to cocaine (48.4%) and fewer related to opioids (12.4%) than the other areas. The Spanish patients were younger (32.2 years) on average than those in northern Europe and older than those in the UK and Ireland and central Europe. Fewer patients were women in Spain (21.9%) than in northern or central Europe. Fewer arrived in ambulances in Spain (70.0%) than in the UK and Ireland or northern Europe. The Spanish EDs recorded the temperature and respiratory frequency of fewer patients (29.8% and 30.3%, respectively). Clinical signs differed between geographical areas attributable to differences in drug-use patterns. In Spain, naloxone was used by fewer patients (9.6%) than in the UK and Ireland and northern Europe, and flumazenil was used by more patients (5.6%) than in other areas. Spain saw lower percentages of admissions (4.6%) and patients who left without an ED discharge (6.2%) in comparison with other areas. Mortality rates in the Spanish EDs (0.4%) and after discharge from them (0.7%) were higher than in northern Europe. CONCLUSION: The characteristics of emergencies related to recreational drug abuse registered by the Spanish EDs were differed from those registered in other parts of Europe due to different patterns of drug use. We also detected differences between the Spanish and other European EDs with respect to examinations or tests performed, treatment given, and discharge disposition

Emergencies related to recreational drug abuse in Spain compared to emergencies attended in 3 European areas.

OBJECTIVES To analyze epidemiologic, clinical, and care characteristics in cases in which patients came to 2 Spanish emergency departments (EDs) with symptoms caused by recreational drug abuse. To compare the characteristics with those reported for other areas of Europe. MATERIAL AND METHODS Secondary analysis of the registry of the European Drug Emergencies Network (Euro-DEN Plus), which collects cases in 14 European countries and 20 EDs. The registry included all patients attending EDs with symptoms of recreational drug abuse (excepting cases involving alcohol alone) over a period of 39 consecutive months (October 2013 to December 2016). We compared the cases from the 2 Spanish EDs (in Barcelona and Palma de Mallorca) to those from the 5 EDs in Ireland and the UK, 6 in northern Europe, and 7 in central Europe. RESULTS A total of 17 104 patients' cases were included: Spain, 1186; UK and Ireland, 6653; northern Europe, 6097; and central Europe, 3168. Spain saw more emergencies related to cocaine (48.4%) and fewer related to opioids (12.4%) than the other areas. The Spanish patients were younger (32.2 years) on average than those in northern Europe and older than those in the UK and Ireland and central Europe. Fewer patients were women in Spain (21.9%) than in northern or central Europe. Fewer arrived in ambulances in Spain (70.0%) than in the UK and Ireland or northern Europe. The Spanish EDs recorded the temperature and respiratory frequency of fewer patients (29.8% and 30.3%, respectively). Clinical signs differed between geographical areas attributable to differences in drug-use patterns. In Spain, naloxone was used by fewer patients (9.6%) than in the UK and Ireland and northern Europe, and flumazenil was used by more patients (5.6%) than in other areas. Spain saw lower percentages of admissions (4.6%) and patients who left without an ED discharge (6.2%) in comparison with other areas. Mortality rates in the Spanish EDs (0.4%) and after discharge from them (0.7%) were higher than in northern Europe. CONCLUSION The characteristics of emergencies related to recreational drug abuse registered by the Spanish EDs were differed from those registered in other parts of Europe due to different patterns of drug use. We also detected differences between the Spanish and other European EDs with respect to examinations or tests performed, treatment given, and discharge disposition

Intoxication by gamma hydroxybutyrate and related analogues: Clinical characteristics and comparison between pure intoxication and that combined with other substances of abuse.

OBJECTIVE To study the profile of European gamma-hydroxybutyrate (GHB) and gammabutyrolactone (GBL) intoxication and analyse the differences in the clinical manifestations produced by intoxication by GHB/GBL alone and in combination with other substances of abuse. METHOD We prospectively collected data on all the patients attended in the Emergency Departments (ED) of the centres participating in the Euro-DEN network over 12 months (October 2013 to September 2014) with a primary presenting complaint of drug intoxication (excluding ethanol alone) and registered the epidemiological and clinical data and outcomes. RESULTS We included 710 cases (83% males, mean age 31 years), representing 12.6% of the total cases attended for drug intoxication. Of these, 73.5% arrived at the ED by ambulance, predominantly during weekend, and 71.7% consumed GHB/GBL in combination with other substances of abuse, the most frequent additional agents being ethanol (50%), amphetamine derivatives (36%), cocaine (12%) and cannabis (8%). Among 15 clinical features pre-defined in the project database, the 3 most frequently identified were altered behaviour (39%), reduced consciousness (34%) and anxiety (14%). The severity ranged from mild cases requiring no treatment (308 cases, 43.4%) to severe cases requiring admission to intensive care (103 cases, 14.6%) and mechanical ventilation (49 cases, 6.9%). No deaths were reported. In comparison with only GHB/GBL consumption, patients consuming GHB/GBL with co-intoxicants presented more vomiting (15% vs. 3%, p12h, p<0.01). CONCLUSIONS The profile of the typical GHB/GBL-intoxicated European is a young male, requiring care for altered behaviour and reduced level of consciousness, mainly during the weekend. The clinical features are more severe when GHB is consumed in combination with other substances of abuse